BOSTON & MONTREAL, June 04, 2025--enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), a clinical-stage, ...

“With a potentially best-in-class bladder cancer therapy and two de-risked rare disease programs, Protara has the opportunity to meaningfully impact patient outcomes,” said Mr. Conkling.“I look ...

Ore grades and production at Pinyon Plain mine continue to exceed historic records and expectations; Energy Fuels' rapid uranium production ramp-up and large "pipeline" uranium development projects ...

Stinchcombe, MD. Tarlatamab, a half-life extended bispecific T-cell engager (HLE BiTE) molecule, binds both DLL3 on cancer cells and CD3 on T cells leading to T-cell–mediated tumor lysis. Tarlatamab ...

Researchers may be one step closer to unravelling the cause of a colon cancer crisis in relatively young people. They've ...

Here the authors report a platform integrating antigen-capturing nanoparticles and type 1 conventional dendritic cells for in situ cancer immunization, promoting anti-tumor immunity in preclinical ...

Here this group develops a nanovaccine delivering nAg and induce in situ cancer vaccination to synergistically promote a personalized immune response, enhance antigen diffusion, and improve the ...

Singer Jessie J took to Instagram to share her breast cancer diagnosis with her fans. Here, we explain what early-stage breast cancer means, what treatment looks like, and how Jessie J is handling her ...